Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA Nephropathy-Reference-Cited by-同舟云学术

Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA Nephropathy

Published:2023-12 Issue:12 Volume:8 Page:2546-2556
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Tam Frederick W.K.,Tumlin James,Barratt Jonathan,Rovin Brad H.,Roberts Ian S.D.,Roufosse Candice,Cook H. Terence,Bhangal Gurjeet,Brown Alison L.,Busch Martin,Dudhiya Fayaz,Duliege Anne-Marie,Fraser Donald J.,Gale Daniel P.,Huang Chiu-Ching,Lai Ping-Chin,Lee Meng,Masuda Esteban S.,McAdoo Stephen P.,Rosenkranz Alexander R.,Sommerer Claudia,Sunder-Plassmann Gere,Szeto Cheuk-Chun,Tang Sydney C.W.,Williamson Don E.,Willcocks Lisa,Vielhauer Volker,Kim Min Jeong,Todd Leslie,Zayed Hany,Tong-Starksen Sandra,Lafayette Richard

Publisher

Elsevier BV

Subject

Nephrology

Reference21 articles.

1. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes;Berthelot;Kidney Int,2015

2. Intensive supportive care plus immunosuppression in IgA nephropathy;Rauen;N Engl J Med,2015

3. Evaluating a new international risk-prediction tool in IgA nephropathy;Barbour;JAMA Intern Med,2019

4. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy;Manno;Nephrol Dial Transplant,2009

5. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial;Pozzi;J Am Soc Nephrol,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs in Development to Treat IgA Nephropathy;Drugs;2024-05

2. Biologics and Non-Biologics Immunosuppressive Treatments for IgA Nephropathy in Both Adults and Children;Journal of Clinical Medicine;2024-04-23

3. Sibeprenlimab bei Patienten mit IgA-Nephropathie;Die Nephrologie;2024-03-07